SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Viyash Scientific signs binding agreement to acquire 100% stake in BFL

08 Jun 2026 Evaluate

Viyash Scientific, through its wholly owned subsidiary Alivira Animal Health (Alivira), has signed a binding agreement to acquire 100% stake in BioForLife Italia S.r.l. (BFL), a leading pet care company based in Milan, Italy. The acquisition, for a cash consideration of around Rs 188 crore is expected to close in Q2 FY27. The transaction represents a significant step in the company’s strategy to capitalize on the mega-trend of a growing companion Animal Health Generics market. It expands Alivira’s global Companion Animal Health business and strengthens its presence in the European pet care market.

BFL, based in Milan, Italy, specializes in the development, commercialization and distribution of pet care products. With a strong product portfolio and pipeline for pet health, BFL has established strong positions in nutritional complements, pharmaceuticals, and rapid diagnostic tests. BFL is also building a business in fast growing segments like dermatology and ophthalmology. With a well-established front-end sales team, BFL reaches over 80% of all veterinary clinics in Italy, thereby providing well-established customer relationships for future growth.

The acquisition will provide a platform for launching new products from Alivira’s pipeline in Italy, while simultaneously providing opportunities to expand the BFL range to other markets in the Alivira group located in Europe, Middle East, Asia and Latam.

Viyash Scientific (formerly known as Sequent Scientific) headquartered in India is globally among the leading Animal Health companies. It is an integrated pharmaceutical company having a rich portfolio of formulations and APIs for human and veterinary use, serving customers in 100 plus countries.

Viyash Scientific Share Price

261.45 4.15 (1.61%)
10-Jun-2026 10:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1785.20
Dr. Reddys Lab 1273.40
Cipla 1383.70
Zydus Lifesciences 1114.00
Lupin 2270.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×